Cargando…
Role of Immune Checkpoint Inhibitors in Advanced or Recurrent Endometrial Cancer
Currently, treatment options for patients with advanced or recurrent endometrial cancer remain limited. The current standard of care treatment for advanced endometrial carcinoma is a platinum doublet chemotherapy. Second-line treatment options overall are very limited. There is no optimal treatment...
Autores principales: | Arora, Ena, Masab, Muhammad, Mittar, Priyanka, Jindal, Vishal, Gupta, Sorab, Dourado, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015998/ https://www.ncbi.nlm.nih.gov/pubmed/29942724 http://dx.doi.org/10.7759/cureus.2521 |
Ejemplares similares
-
Role of Poly Adenosine Diphosphate Ribose Polymerase Inhibitors in Advanced Stage Ovarian Cancer
por: Arora, Ena, et al.
Publicado: (2018) -
Metastatic Sternal Osteosarcoma: A Rare Tumor
por: Masab, Muhammad, et al.
Publicado: (2018) -
Influence of Microbiome and Antibiotics on the Efficacy of Immune Checkpoint Inhibitors
por: Patel, Priyanka, et al.
Publicado: (2021) -
Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis
por: Verma, Neha, et al.
Publicado: (2021) -
Acquired Gitelman Syndrome Associated with Systemic Sclerosis
por: Masab, Muhammad, et al.
Publicado: (2019)